Jacobs Engineering Group Inc. (NYSE: NYSE:J) has emerged as a pure-play Engineering Services and Consulting firm, following the spin-off of its CMS/C&I segment in September 2024. The company has ...

Kura Oncology, Inc. (NASDAQ:KURA), a clinical-stage biopharmaceutical company focused on developing precision medicines for cancer treatment, is approaching a critical juncture in its development ...